The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)? (SYNCOMOT)

October 12, 2022 updated by: Centre Hospitalier Universitaire, Amiens

Stroke is the leading cause of severe disability in adults. The first cause of alterations in the quality of life and autonomy in these patients are disorders of walking and the balance. They are the leading cause of falls responsible for important medical, surgical and economic complications as well as a reactionary social isolation.

The techniques of rehabilitation of walking to the subacute phase of a stroke are usually based on automatic walking.Off walking is a complex activity usually performed in everyday life in association with multiple tasks. It is therefore interesting to re-educate walking in dual task or even in multitasking.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Major: age between 18 and 90 years
  • Hospitalized for ischemic or hemorrhagic hemispheric stroke confirmed by CT or MRI <6months
  • walking disorder with the possibility of walking 10 meters with or without technical assistance (speed <1.2m / s)
  • verbal understanding with complex orders
  • Affiliates to social security

Exclusion Criteria:

  • Brainstem stroke or cerebellar
  • Hypoacusia annoying understanding
  • Visual gene embarrassing awarding
  • severe aphasia: no understanding of complex orders
  • neurological or musculoskeletal history affecting walking
  • Participation in interventional research protocol in motor rehabilitation of the lower limb or cognitive
  • Patient under guardianship or deprived of liberty
  • pregnant women, parturient women or lactating (art L.1121-5)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: multitasking walking
Multitasking Group: rehabilitation multitasking walking.
rehabilitation multitasking walking.
Active Comparator: walking simple task
Simple task group : Traditional walking rehabilitation
Traditional walking rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure walking speed
Time Frame: 6 months
Speed of the simple task of walking 10 meters testing.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of different types of walking disorders and balance in the subacute phase of stroke
Time Frame: inclusion
Currently no clinical scale exists in the literature at our knowledge. The walk of the patients will be qualitatively analyzed by the investigator in order to measure the prevalence of the different clinical categories of walking disorders according to their semiological characteristics
inclusion
Score neuromotor the lower limb
Time Frame: 6 months
Score neuromotor the lower limb: Fugl Meyer
6 months
Dynamic equilibrium to TUG single and double cognitive task
Time Frame: 6 months
Dynamic equilibrium to TUG single and double cognitive task
6 months
Walking speed double cognitive task
Time Frame: 6 months
Walking speed double cognitive task
6 months
Executive functions: a battery of neuropsychological
Time Frame: 6 months
Executive functions: a battery of neuropsychological
6 months
Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT
Time Frame: 6 months
Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT
6 months
EVA Quality of life
Time Frame: 6 months
EVA (Visual Analogic Scale) quality of life
6 months
Correlation of cognitive gains with the gain of the walking speed of 10 meters
Time Frame: 6 months
Correlation of cognitive gains with the gain of the walking speed of 10 meters
6 months
anatomoclinical correlations
Time Frame: 6 months
Lesion score of gray matter and white matter (Volumetry on sequences 3DT1 and Flair) Cerebral
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sophie TASSEEL-PONCHE, Doctor, CHU Amiens-Picardie France
  • Principal Investigator: Eric VERIN, professor, CHU de Rouen
  • Principal Investigator: Etienne ALLART, Doctor, Chru De Lille
  • Principal Investigator: DEMAILLE Samantha, professor, CRF 4Espoir Lille
  • Principal Investigator: Valérie LECLERCQ-DONTGEZ, Doctor, Les 3 vallées
  • Principal Investigator: Haykal ELLEUCH, Doctor, CH ARRAS
  • Principal Investigator: Marie DECOCQ-DEMICHEL, Doctor, CH Le Belloy
  • Principal Investigator: Pascal RIGAUX, Doctor, CH Berck Sur Mer
  • Principal Investigator: Sabine POL-ROUX, Doctor, CH Compiègne
  • Principal Investigator: Sofiane LARIBI, Doctor, CH Breteuil
  • Principal Investigator: Skander MOALLA, Doctor, Centre Hospitalier de Beauvais

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2017

Primary Completion (Anticipated)

May 10, 2023

Study Completion (Anticipated)

May 10, 2024

Study Registration Dates

First Submitted

November 14, 2016

First Submitted That Met QC Criteria

January 2, 2017

First Posted (Estimate)

January 4, 2017

Study Record Updates

Last Update Posted (Actual)

October 14, 2022

Last Update Submitted That Met QC Criteria

October 12, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacute Stroke

Clinical Trials on rehabilitation multitasking walking.

Subscribe